Texas SB 3 Ban: Impact on Hemp, Health & Plant Medicine

As Texas moves closer to enacting one of the most sweeping Texas SB3 hemp ban policies in the country, patients, small businesses, and plant medicine advocates are raising urgent concerns. Senate Bill 3 (SB 3), spearheaded by Lt. Gov. Dan Patrick and State Senator Charles Perry, does not just regulate THC, but proposes to ban it outright, eliminating legal access to a wide range of federally compliant hemp-derived cannabinoids, including delta 8 THC and delta 9 THC.

The implications reach far beyond store shelves. This bill threatens the medical freedom of countless Texans who rely on these compounds for pain relief, anxiety, sleep, and even cancer-related symptoms. It puts jobs and small businesses at risk, and directly contradicts research, data, and the public health principles that should guide cannabis policy.

Let’s dive into what exactly SB3 means for the citizens of Texas.

Senate Bill 3 Overview

Senate Bill 3 would ban the manufacture, sale, and possession of any hemp-derived cannabinoid product deemed “intoxicating.” This includes widely used compounds like delta-8 THC and hemp-derived delta-9 THC, even when these products contain less than the federally legal limit of 0.3% delta-9 THC by dry weight. Only CBD and CBG would remain legal under the bill’s provisions.

Additionally, retailers would need to register every store location with the Texas Department of State Health Services and pay additional fees, comply with new labeling and testing rules, and ensure every product is sold only to adults aged 21 and over. Violations would carry steep consequences ranging from Class A to Class B misdemeanors to potential jail time.

Governor Abbott has until June 22, 2025, to either veto, sign the bill, or allow it to pass without a signature. If it passes, Senate Bill 3 will go into effect on September 1, 2025, reshaping cannabinoid access across the state.

Impact on Patients and Medical Freedom

The reality is that delta 8 and delta 9 THC are not just alternatives to cannabis for recreational use. These compounds play a critical role in symptom relief for thousands of Texans who do not qualify for the state’s extremely limited medical marijuana program, or for those who cannot afford it.

Delta-8 THC, for instance, has been shown in studies to reduce nausea and vomiting in cancer patients undergoing chemotherapy. In a 1995 study, delta 8 was given to 8 children undergoing chemotherapy. Researchers followed the children over a period of 2 years and a total of 480 combined chemotherapy treatments. Remarkably, not a single participant experienced vomiting during the trial. In fact, the results were so promising that in 2006, a US patent was filed for the use of Delta 8 along with CBD for use as an anti-nausea, citing that Delta 8 was 200% more effective than Delta 9 THC for this therapeutic use. Along with anti-nausea effects, delta 8 THC has demonstrated a range of benefits, including pain relief and appetite support. Many patients prefer delta 8 as it has a gentler psychoactive profile, making it more tolerable for those who need relief without inducing the euphoria of traditional cannabis.

Likewise, hemp-derived delta-9 THC boasts a wide range of therapeutic benefits that can help individuals manage chronic pain, insomnia, anxiety, muscle spasms, and inflammation, along with other ailments and symptoms that disrupt their quality of life.

For many Texans, especially those living in rural areas or facing financial or medical barriers, these hemp-derived products represent the only accessible and affordable pathway to relief. With the state’s highly limited medical cannabis program and ongoing legal ambiguity surrounding traditional THC, products made from federally legal hemp offer a critical lifeline for patients who would otherwise go without effective treatment. By banning these compounds, Texas lawmakers are not protecting public health; they’re cutting off access to plant-based therapies that offer genuine relief to real people.

Economic Consequences for Small Businesses

The impact of SB 3 wouldn’t stop with patients. It will ripple across communities, shutting down small businesses and dismantling a thriving industry that has become a vital part of Texas’s economy. From rural farmers growing legal hemp to veteran-owned wellness shops and minority entrepreneurs, tens of thousands of Texans stand to lose their livelihoods. In fact, the state’s hemp industry supports over 50,000 jobs and contributes billions of dollars to the economy. Banning all hemp-derived THC products would gut this sector overnight.

Additionally, pushing people out of the legal market will not end demand like those championing this bill believes. Instead, it will drive it underground, into a black market with no regulation, no quality control, and no consumer safety standards. This is not mere speculation, it is exactly what prohibition has done time and time again.

This bill criminalizes nonviolent behavior, restricts access to essential wellness tools, and deepens the risk for marginalized communities that are already overpoliced. Prohibition doesn’t solve problems, it creates them.

Public Health & Youth Use Myths

Supporters of SB 3 argue that the bill is necessary to protect children, claiming that hemp-derived THC products are marketed to minors and pose a public health risk. But this framing doesn’t hold up to scrutiny.

Decades of data from states with legal cannabis programs show that legalization does not lead to increased youth use. In fact, studies show that teen marijuana use often declines when regulated markets are paired with education, enforcement of age restrictions, and proper labeling and packaging.

A 2022 study published in JAMA Pediatrics found no increase in adolescent cannabis use following legalization. The key factor? States that emphasized education and access control, not blanket bans.

If the goal is truly to protect children, then Texas should invest in strong regulatory systems, age verification protocols, and public health education, not policies that push access into the shadows.

The Case for Regulated Plant Medicine

Plant-based medicine is not the enemy. Hemp, cannabis, and their derivatives have been used around the world for thousands of years to support wellness, ease suffering, and improve quality of life. As modern research continues to affirm their safety and efficacy, the question is not whether these compounds belong in society; it’s how we ensure they’re used safely and responsibly.

However, SB 3 does not do that. Instead of creating safeguards, it removes options. Instead of promoting health, it punishes those seeking relief. And instead of regulating a growing industry, it attempts to erase it. This is not a step toward public safety. It’s a step backward; a refusal to listen to science, to patients, and to the real-world evidence from other states. The bill will not eliminate demand. It will eliminate safety.

Final Thoughts: Texans Deserve Better

Senate Bill 3 is not just a ban on cannabinoids; it’s a rejection of patient choice, industry growth, and research. As the bill moves forward, Texans have a narrow window to raise their voices, share their stories, and push back against policies rooted in fear rather than facts.

Access to plant medicine is a personal, medical, and human rights issue. Texans deserve regulation, not restriction. Progress, not punishment. And above all, they deserve the freedom to choose the wellness tools that work best for them.